Within this framework, the purpose of our study was to evaluate the association between the NUDT15*3 variant—along with TPMT*3A, *3B, and *3C risk haplotypes—and the response and toxicity of thiopurine therapy in a cohort of Italian IBD patients. This evidence concerns the gene NUDT15 and inflammatory bowel disease.